A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708
This study is recruiting at 7 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Pancreatic Cancer
- Pancreatic Diseases
- Pancreatitis
- Pancreatic Cyst
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Last updated on ClinicalTrials.gov
- August 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New Jersey · 2
- Memorial Sloan Kettering Monmouth (All protocol activities) · Middletown, NJ
- Memorial Sloan Kettering Bergen (All protocol activities) · Montvale, NJ
New York · 5
- Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities) · Commack, NY
- Memorial Sloan Kettering Westchester (All protocol activities) · Harrison, NY
- Memorial Sloan - Kettering Cancer Center · New York, NY
- Memorial Sloan Kettering Basking Ridge (All protocol activities) · New York, NY
- Memorial Sloan Kettering Nassau (All protocol activities) · Rockville Centre, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.